Mitochondria in Retinal Ganglion Cells
About the Research Project
Program
Award Type
Standard
Award Amount
$182,000
Active Dates
July 01, 2025 - June 30, 2027
Grant ID
G2025003S
Goals
Characterize the biology of mitochondria in the RGC dendritic compartment, with particular emphasis on how these organelles are turned over before and after optic nerve damage.
Summary
Retinal ganglion cells receive input from a tree-like dendritic arbor that exhibits pathology after optic nerve damage. This study examines the biology of energy producing organelles called mitochondria in arbor pathology including how specialized cells called microglia participate in this process.
Unique and Innovative
This marks the first time anyone has mapped mitochondria in the dendritic arbors of ganglion cells.
Foreseeable Benefits
Ganglion cells are also really sensitive to abnormalities in mitochondria – the powerhouse organelle in every cells that makes energy. It is so profound, that mutations that affect mitochondrial function in every cell lead to optic nerve disease as sometimes the only consequence. We hope that this study will help us better understand why ganglion cells are so sensitive to mitochondrial function which could lead to the development of novel treatments to enhance ganglion cell resilience.
Related Grants
National Glaucoma Research
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
W. Daniel Stamer, PhD
Current Organization
Duke University
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
W. Daniel Stamer, PhD
Current Organization
Duke University